Novo Nordisk wins Dutch injunction against compounded semaglutide spray
The Dutch court order targets a nasal spray formulation of compounded semaglutide, extending Novo's litigation against unapproved copies into Europe.
DO
By Daniel Okafor · Regulatory Correspondent
Aug 8 03:00 ETSource: Yahoo Finance
The wire
- 01Novo Nordisk obtained an injunction in the Netherlands against a compounded semaglutide spray product.
- 02The ruling signals that Novo's campaign against compounded and alternative-route semaglutide is not limited to US pharmacies and telehealth sellers.
- 03Terms of the injunction, the defendant's appeal options and any penalties were not detailed in the report.
From the source
Read at finance.yahoo.comNovo Nordisk (CPSE:NOVO B) Wins Dutch Injunction Over Compounded Semaglutide Spray
